182 related articles for article (PubMed ID: 10965635)
1. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples.
Franklin ME; Abramowitz JS; Kozak MJ; Levitt JT; Foa EB
J Consult Clin Psychol; 2000 Aug; 68(4):594-602. PubMed ID: 10965635
[TBL] [Abstract][Full Text] [Related]
2. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
[TBL] [Abstract][Full Text] [Related]
3. How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis.
Fisher PL; Wells A
Behav Res Ther; 2005 Dec; 43(12):1543-58. PubMed ID: 16239151
[TBL] [Abstract][Full Text] [Related]
4. Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.
van Oppen P; van Balkom AJ; Smit JH; Schuurmans J; van Dyck R; Emmelkamp PM
J Clin Psychiatry; 2010 Sep; 71(9):1158-67. PubMed ID: 20361906
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of moderate-intensity aerobic exercise for obsessive compulsive disorder.
Brown RA; Abrantes AM; Strong DR; Mancebo MC; Menard J; Rasmussen SA; Greenberg BD
J Nerv Ment Dis; 2007 Jun; 195(6):514-20. PubMed ID: 17568300
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence.
Bolton D; Perrin S
J Behav Ther Exp Psychiatry; 2008 Mar; 39(1):11-22. PubMed ID: 17207457
[TBL] [Abstract][Full Text] [Related]
7. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment.
Saxena S; Maidment KM; Vapnik T; Golden G; Rishwain T; Rosen RM; Tarlow G; Bystritsky A
J Clin Psychiatry; 2002 Jan; 63(1):21-7. PubMed ID: 11838621
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
[TBL] [Abstract][Full Text] [Related]
9. Electroacupuncture for refractory obsessive-compulsive disorder: a pilot waitlist-controlled trial.
Zhang ZJ; Wang XY; Tan QR; Jin GX; Yao SM
J Nerv Ment Dis; 2009 Aug; 197(8):619-22. PubMed ID: 19684500
[TBL] [Abstract][Full Text] [Related]
10. Intensive outpatient treatment for obsessive-compulsive spectrum disorders.
Ben-Arush O; Wexler JB; Zohar J
Isr J Psychiatry Relat Sci; 2008; 45(3):193-200. PubMed ID: 19398823
[TBL] [Abstract][Full Text] [Related]
11. Treatment compliance and outcome in obsessive-compulsive disorder.
Abramowitz JS; Franklin ME; Zoellner LA; DiBernardo CL
Behav Modif; 2002 Sep; 26(4):447-63. PubMed ID: 12205821
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder.
Watson HJ; Rees CS
J Child Psychol Psychiatry; 2008 May; 49(5):489-98. PubMed ID: 18400058
[TBL] [Abstract][Full Text] [Related]
13. Florida Obsessive-Compulsive Inventory: development, reliability, and validity.
Storch EA; Kaufman DA; Bagner D; Merlo LJ; Shapira NA; Geffken GR; Murphy TK; Goodman WK
J Clin Psychol; 2007 Sep; 63(9):851-9. PubMed ID: 17674398
[TBL] [Abstract][Full Text] [Related]
14. Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine.
Chasson GS; Buhlmann U; Tolin DF; Rao SR; Reese HE; Rowley T; Welsh KS; Wilhelm S
Behav Res Ther; 2010 Jul; 48(7):675-9. PubMed ID: 20362975
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder.
Poyurovsky M; Faragian S; Shabeta A; Kosov A
Psychiatry Res; 2008 May; 159(1-2):133-9. PubMed ID: 18406469
[TBL] [Abstract][Full Text] [Related]
16. Thematic similarity and clinical outcome in obsessive-compulsive disorder group treatment.
Norton PJ; Whittal ML
Depress Anxiety; 2004; 20(4):195-7. PubMed ID: 15580573
[TBL] [Abstract][Full Text] [Related]
17. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
Etain B; Bonnet-Perrin E
Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
[TBL] [Abstract][Full Text] [Related]
18. Insight in pediatric obsessive-compulsive disorder: associations with clinical presentation.
Storch EA; Milsom VA; Merlo LJ; Larson M; Geffken GR; Jacob ML; Murphy TK; Goodman WK
Psychiatry Res; 2008 Aug; 160(2):212-20. PubMed ID: 18556071
[TBL] [Abstract][Full Text] [Related]
19. Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview.
du Toit PL; van Kradenburg J; Niehaus D; Stein DJ
Compr Psychiatry; 2001; 42(4):291-300. PubMed ID: 11458303
[TBL] [Abstract][Full Text] [Related]
20. [Drug treatment of obsessive-compulsive disorder. With proper drugs and some patience many patients can be helped].
Mavrogiorgou P; Hegerl U
MMW Fortschr Med; 1999 Sep; 141(39):32-4, 37. PubMed ID: 10897982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
